Form 4 for TWST Twist Bioscience Corp
Accepted 2021-11-19 00:00:00 ET · period of report 2021-11-17 · accession 0001214659-21-012082 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-19 | 2021-11-17 | TWST | JOHANNESSEN JAN | Dir | M - OptEx | $14.00 | +5,000 | 6,898 | +263% | +$70.0K |
| D | 2021-11-19 | 2021-11-17 | TWST | JOHANNESSEN JAN | Dir | S - Sale+OE | $115.17 | -5,000 | 1,898 | -72% | -$575.9K |
| D | 2021-11-19 | 2021-11-17 | TWST | JOHANNESSEN JAN | Dir | M - OptEx | $0.00 | -5,000 | 27.3K | -15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-17 | M | A | 5,000 | $14.00 | 6,898 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-17 | S | D | 5,000 | $115.17 | 1,898 | D | — | — | |
| 3 | Derivative | Director Stock Option (right to buy) | 2021-11-17 | M | D | 5,000 | $0.00 | 27,304 | D | $14.00 · — to 2028-10-29 | 5,000 Common Stock | (F2) 1/3rd of the shares subject to the option vested and became exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vest and become exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |